全球生物活性材料市场规模、份额、成长分析（按类型、按应用） - 产业预测，2023-2030 年

Global Bioactive Materials Market Size, Share, Growth Analysis, By Type(Natural Biomaterial, Metallic Biomaterial), By Application(Neurology, Cardiology) - Industry Forecast 2023-2030

出版日期: 2024年02月17日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球生物活性材料市场规模估值为22.6亿美元，从2023年的25.5亿美元增长到2031年的67.9亿美元，在预测期内（2024-2031年）预计复合年增长率为13 %。

由于对先进植入材料的需求不断增加以及对传统金属植入的担忧日益增加，导致市场出现模式转移增长的迹象。生物活性材料以其与体液和组织的强结合能力而闻名，在用于组织癒合和修復的医疗和医学领域以及抗菌产品、药品和化妆品的生产中越来越受追捧。为此，刺激市场的扩大。凭藉细胞移植、修復、再生和重组的专业化，在各种整形外科手术和生物工程计划中的广泛采用对于推动市场向前发展至关重要。儘管耐磨损、耐细菌渗透和防潮，但市场扩张可能会受到先进加工工具和技术需要大量初始投资的限制。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东/非洲
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2021年）
主要市场参与者所采取的策略
关键成功策略
近期市集活动
主要企业市场占有率（2021年）

主要企业简介

美敦力公司（爱尔兰）
赢创工业股份公司（德国）
卡本特科技公司（美国）
柏克莱先进生物材料（美国）
Invibio 有限公司（英国）
Zimmer Biomet Holdings, Inc.（美国）
BASF公司（德国）
Covalon 技术有限公司（加拿大）
史赛克（美国）
强生公司（美国）
登士柏西诺德（美国）
CoorsTek Inc.（美国）
Corbion（荷兰）
皇家帝斯曼公司（荷兰）
3M公司（美国）
Amedica 公司（美国）
Ceramtec 有限公司（德国）
Cam Bioceramics（韩国）
Alphatec Spine, Inc.（美国）
莱特医疗集团有限公司（美国）

简介目录

Product Code: SQMIG35H2177

Global Bioactive Materials Market size was valued at USD 2.26 billion in 2022 and is poised to grow from USD 2.55 billion in 2023 to USD 6.79 billion by 2031, growing at a CAGR of 13% during the forecast period (2024-2031).

The market is on the cusp of significant growth driven by escalating demand for advanced implantable materials and growing apprehensions about traditional metal implants, prompting a paradigm shift. Bioactive materials, renowned for their robust bonding capabilities with fluids and tissues, are increasingly sought after in medical and healthcare domains for tissue healing and repair, as well as in the production of antibacterial products, pharmaceuticals, and cosmetics, thereby fueling market expansion. Their widespread adoption in various orthopedic surgeries and bioengineering endeavors is pivotal in advancing the market, given their specialization in cellular transplants, repair, regeneration, and reconstruction. Despite their resilience to wear, bacterial infiltration, and moisture, the market's expansion might be tempered by the significant initial investment required for sophisticated processing tools and technology.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bioactive Materials Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bioactive Materials Market Segmental Analysis

The global bioactive materials market is segmented on the basis of type, application, region. By type, the market is segmented into powder, moldable, granules, and others. By application, the market is segmented into dentistry, surgery, bioengineering, others. By region, the market is segmented into North America, Europe, Latin America, Asia- Pacific, Middle East and Africa.

Drivers of the Global Bioactive Materials Market

One of the primary factors driving the Global Bioactive Materials Market is the rising demand within the healthcare sector, particularly for orthopedic surgeries and tissue engineering applications. The increasing focus on advanced implantable materials that demonstrate strong bonding capabilities with fluids and tissues has led to bioactive materials becoming favored by both medical practitioners and researchers. Their effectiveness in tissue healing, repair, and regeneration, along with their potential for producing antibacterial products, pharmaceuticals, and cosmetics, further solidifies their market demand. With healthcare technologies advancing and concerns regarding traditional metal implants remaining, bioactive materials are poised to experience continuous growth in the foreseeable future.

Restraints in the Global Bioactive Materials Market

A major impediment facing the Global Bioactive Materials Market is the significant expenses tied to research and development (R&D). The creation of bioactive materials requires thorough research, experimentation, and validation procedures to guarantee their effectiveness, safety, and adherence to regulatory requirements, necessitating substantial investments in advanced laboratories, specialized equipment, expert staff, and clinical trials. Moreover, the ongoing demand for innovation and enhancement to maintain competitiveness exacerbates R&D spending. Consequently, the substantial R&D costs present a substantial obstacle for smaller enterprises and startups seeking entry into the market, potentially constraining overall market growth despite its optimistic outlook.

Market Trends of the Global Bioactive Materials Market

An emerging trend in the global bioactive materials market is the integration of nanotechnology, which involves manipulating materials at the nanoscale to enhance their properties and performance. Nanotechnology offers the potential to revolutionize bioactive materials by enabling precise control over their structure and functionality, leading to improvements in biocompatibility, durability, and therapeutic efficacy. Through the incorporation of nanoparticles and nanostructures, bioactive materials can achieve enhanced drug delivery, tissue regeneration, and antimicrobial properties, opening up new opportunities for applications in medical implants, drug delivery systems, and tissue engineering. As research and development in nanotechnology continue to advance, the integration of nanomaterials is expected to drive innovation and competitiveness within the global bioactive materials market, further propelling its growth and expansion.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Bioactive Materials Market by Type

Market Overview
Natural Biomaterial
Metallic Biomaterial
Ceramic Biomaterial
and Polymeric Biomaterial

Global Bioactive Materials Market by Application

Market Overview
Neurology
Cardiology
Orthopedics
Ophthalmology
Wound Care
Dental
Plastic Surgery
and Other Applications

Global Bioactive Materials Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Evonik Industries AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Carpenter Technology Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Berkeley Advanced Biomaterials (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Invibio Ltd (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zimmer Biomet Holdings, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BASF SE (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Covalon Technologies Ltd (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dentsply Sirona (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CoorsTek Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Corbion (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Royal DSM NV (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
3M Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amedica Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ceramtec GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cam Bioceramics (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alphatec Spine, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wright Medical Group, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments